1-2 of 2
Alessandro Petrucci, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Prospective, Randomized Study of Melphalan, Prednisone, Lenalidomide (MPR) versus Melphalan (200 Mg/M 2 ) and Autologous Transplantation (Mel200) in Newly Diagnosed Myeloma Patients: An Interim Analysis.

Antonio Palumbo, MD, Federica Cavallo, MD, Dina Ben Yehuda, MD, Paola Omedè€, PhD, Agostina Siniscalchi, MD, Maide Cavalli, MD, Barbara Lupo, MD, Aaron Polliack, MD, Izhar Hardan, MD, Fabiana Gentilini, MD, Paolo Corradini, MD, Claudia Crippa, MD, Fausto Rossini, MD, Francesca Patriarca, MD, Annalisa Citro, MD, Alessandro Petrucci, MD, Angelo Michele Carella, MD, Giulia Benevolo, MD, Tommaso Caravita, MD, Francesco Di Raimondo, MD, Mario Boccadoro, MD
Journal: Blood
Blood (2009) 114 (22): 350.
https://doi.org/10.1182/blood.V114.22.350.350
Published: 2009
Journal Articles

Bortezomib-Thalidomide-Dexamethasone as Primary Induction Therapy for Newly Diagnosed Multiple Myeloma Significantly Decreases Bone Resorption While Sparing Bone Formation as Compared to Thalidomide-Dexamethasone

Patrizia Tosi, MD, Elena Zamagni, MD, Paola Tacchetti, MD, Giulia Perrone, MD, Michela Ceccolini, MD, Anna Maria Brioli, MD, Maria Caterina Pallotti, MD, Lucia Pantani, MD, Alessandro Petrucci, MD, Michele Baccarani, Michele Cavo, MD
Journal: Blood
Blood (2008) 112 (11): 5117.
https://doi.org/10.1182/blood.V112.11.5117.5117
Published: 2008